Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody
Clinical trial NCT06432296 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06432296
- Sponsor
- Wuhan YZY Biopharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2026-06-12
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.